It has been demonstrated that serum level of HGF significantly correlates with the stage of melanoma [24], although patient evaluation did not provide unambiguous results to validate HGF as a biomarker for melanoma response to BRAF inhibitors [2,5,23–25]. The gene discussed is BRAF; the disease is melanoma.